79
Participants
Start Date
August 31, 2017
Primary Completion Date
November 30, 2022
Study Completion Date
November 5, 2024
The IBD group was divided into 2 subgroups: with or without anti-TNF antibody use
This observational study enrolled women with IBD, and some of them were receiving a treatment with anti-TNF monoclonal antibody, which was prescribed by their responsible prescribers at a standard dose and dosing interval.
Mount Sinai Hospital, Toronto
The Hospital for Sick Children, Toronto
MOUNT SINAI HOSPITAL
OTHER
Crohn's and Colitis Foundation
OTHER
The Hospital for Sick Children
OTHER